Sarcopenia
Human evidence and active trials are visible in this field
535 human-evidence records · 43 active trials · 60 visible funding records · 7,070 universities
Longevity Patent Family
MRPS9 Biomarker composition for diagnosing muscle-aging related diseases comprising MRPS9 protein or gene encoding the same as an active ingredient
Source-linked patent metadata for MRPS9 Biomarker composition for diagnosing muscle-aging related diseases comprising MRPS9 protein or gene encoding the same as an active ingredient, including priority, record stage and longevity-topic connections.
Patent-family snapshot
Application publication visible
Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.
- Representative publication
- KR20260132238A
- Earliest priority
- February 26, 2025
- Latest publication
- September 2, 2026
- Family publications
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Organizations named in this family
Applicant metadata is not available.
Topics connected by metadata
Sarcopenia88% metadata match
What this family cites
- Earlier patent references
- 0
- Scientific and other non-patent references
- 0
- Priority dates represented
- 1
References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.
How the patent office classifies this invention
No patent classification is available in the retained record.
Verify in the original patent source →